| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/08/1996 | DE4427221A1 Retrovirus-induzierte Osteoklasten-Modulation für die Osteoporose-Therapie Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 02/08/1996 | CA2196070A1 Antisense oligonucleotides against hepatitis b viral replication |
| 02/08/1996 | CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | CA2195539A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | CA2195099A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | CA2194973A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/07/1996 | EP0695305A1 Method of forming oligonucleotides |
| 02/07/1996 | EP0695170A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles |
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | US5489514 DNA coding for growth-inhibitory factor and use thereof |
| 02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 02/01/1996 | WO1996002674A1 Genetic diagnosis of prostate cancer |
| 02/01/1996 | WO1996002670A1 Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases |
| 02/01/1996 | WO1996002658A1 A method for large scale plasmid purification |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002646A2 Growth control for cells encapsulated within bioartificial organs |
| 02/01/1996 | WO1996002642A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 02/01/1996 | WO1996002560A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002556A2 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002143A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 02/01/1996 | WO1995023225A3 Method and reagent for inhibiting the expression of disease related genes |
| 02/01/1996 | CA2694296A1 Growth control for cells encapsulated within bioartificial organs |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195533A1 Interruption of binding of mdm2 and p53 protein and therapeutic application thereof |
| 02/01/1996 | CA2195397A1 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | CA2192342A1 A method for large scale plasmid purification |
| 01/31/1996 | EP0694072A1 Transposition assembly for gene transfer in eukaryotes |
| 01/31/1996 | EP0694071A1 Adenovirus for the transfer of foreign dna into higher eucaryotic cells |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694068A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 01/31/1996 | EP0590132A4 -i(in vitro)-derived human neutrophil precursor cells |
| 01/30/1996 | US5487992 Producing a transgenic mouse |
| 01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
| 01/30/1996 | US5487889 Envelope encloses cells that secrete wound healing growth factors; genetic engineering |
| 01/25/1996 | WO1996001902A1 Adenovirus comprising a gene coding for an no synthase |
| 01/25/1996 | WO1996001898A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
| 01/25/1996 | WO1996001893A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001835A1 Mammalian telomerase |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001614A2 Rna component of telomerase |
| 01/25/1996 | WO1996001557A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194768A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | CA2194451A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194447A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2193263A1 Adenovirus comprising a gene coding for an no synthase |
| 01/24/1996 | EP0693287A1 RNA cleaving or binding oligonucleotides |
| 01/24/1996 | EP0693130A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 01/24/1996 | EP0693126A1 Method for selective inactivation of viral replication |
| 01/24/1996 | EP0693123A1 Modified oligonucleotides having improved anti-influenza activity |
| 01/24/1996 | EP0692972A1 Method for delivering beneficial compositions to hair follicles |
| 01/18/1996 | WO1996001324A2 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 01/18/1996 | WO1996001322A1 Serum paraoxonase |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001313A1 Tetracycline-regulated transcriptional modulators |
| 01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2194390A1 Serum paraoxonase |
| 01/18/1996 | CA2194155A1 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0691988A1 Inhibitor of stem cell proliferation and uses thereof |
| 01/17/1996 | EP0691853A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION |
| 01/11/1996 | WO1996000790A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | WO1996000587A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | WO1996000586A2 Methods for treating cell proliferative disorders by modulating signal transduction |
| 01/11/1996 | WO1996000583A1 Polynucleotide vaccine for papillomavirus |
| 01/11/1996 | WO1995031552A3 Human papilloma virus inhibition by a hairpin ribozyme |
| 01/11/1996 | DE4422259A1 Anti-Sinn-Oligonukleotide zur Aromatase-Inhibierung Antisense oligonucleotides for aromatase inhibition |
| 01/11/1996 | CA2193802A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | CA2190883A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/10/1996 | EP0690990A1 Parvovirus receptors and methods of use |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
| 01/10/1996 | EP0690732A1 Gas driven gene delivery instrument |
| 01/10/1996 | EP0690726A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 01/10/1996 | EP0690673A1 Systemic gene treatment of connective tissue diseases |
| 01/10/1996 | EP0599850B1 Composition and method for treating cystic fibrosis |
| 01/10/1996 | EP0487611B1 Herpes simplex virus type 1 mutant |
| 01/04/1996 | WO1996000295A1 Targeted gene delivery system |
| 01/04/1996 | WO1996000294A1 Improvements in or relating to delivery of nucleic acids |
| 01/04/1996 | WO1996000232A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF |
| 01/04/1996 | WO1996000231A1 Anti-sense oligonucleotides for aromatase inhibition |
| 01/04/1996 | WO1996000007A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 01/04/1996 | WO1996000006A1 Inducible nitric oxide synthase gene for treatment of disease |
| 01/04/1996 | WO1995025806A3 Packaging-deficient lentiviruses |